InvestorsHub Logo
Followers 10
Posts 431
Boards Moderated 0
Alias Born 12/11/2012

Re: Auda post# 6916

Wednesday, 03/20/2013 3:10:08 PM

Wednesday, March 20, 2013 3:10:08 PM

Post# of 8779
Thanks Auda. I do appreciate your hard work. I agree that the trials themselves ARE more costly - without question. I go back to a Feb 2012 that can be found on this site, when a poster said he received an email from Withrow himself that said they are PRE-IRB and not even in trials as of yet with no clear date on when anything will happen. My point was the filing of the IRB itself is not exorbitant so when he told the poster that he is still pre filing, that is contrary to everything the campaign itself was gearing the investors up for. In summary it was absolutely misleading. If these are professionals who really want this to succeed, they are not being in the least professional in their treatment of shareholders when all they need to do is put out a notification now and again for us all to read and make decisions on as to say or exit. At this point a lot of people bought in before the name change the fall in share price - hoping that this was a legit company with a good product. The fact they are pre-irb - which is just an independent review prior to a clinical trial - means those ducks we all thought they had in a row, weren't.
Join InvestorsHub

Join the InvestorsHub Community

Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.